1. Home
  2. BBNX vs NXP Comparison

BBNX vs NXP Comparison

Compare BBNX & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • NXP
  • Stock Information
  • Founded
  • BBNX 2015
  • NXP 1992
  • Country
  • BBNX United States
  • NXP United States
  • Employees
  • BBNX N/A
  • NXP N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • NXP Trusts Except Educational Religious and Charitable
  • Sector
  • BBNX Health Care
  • NXP Finance
  • Exchange
  • BBNX Nasdaq
  • NXP Nasdaq
  • Market Cap
  • BBNX 649.9M
  • NXP 730.9M
  • IPO Year
  • BBNX 2025
  • NXP N/A
  • Fundamental
  • Price
  • BBNX $12.67
  • NXP $13.93
  • Analyst Decision
  • BBNX Strong Buy
  • NXP
  • Analyst Count
  • BBNX 10
  • NXP 0
  • Target Price
  • BBNX $25.20
  • NXP N/A
  • AVG Volume (30 Days)
  • BBNX 467.2K
  • NXP 70.0K
  • Earning Date
  • BBNX 07-29-2025
  • NXP 01-01-0001
  • Dividend Yield
  • BBNX N/A
  • NXP 4.04%
  • EPS Growth
  • BBNX N/A
  • NXP N/A
  • EPS
  • BBNX N/A
  • NXP 0.54
  • Revenue
  • BBNX $69,830,000.00
  • NXP N/A
  • Revenue This Year
  • BBNX $32.79
  • NXP N/A
  • Revenue Next Year
  • BBNX $36.59
  • NXP N/A
  • P/E Ratio
  • BBNX N/A
  • NXP $26.81
  • Revenue Growth
  • BBNX 38911.17
  • NXP N/A
  • 52 Week Low
  • BBNX $8.89
  • NXP $12.91
  • 52 Week High
  • BBNX $24.50
  • NXP $14.89
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • NXP 43.58
  • Support Level
  • BBNX N/A
  • NXP $13.92
  • Resistance Level
  • BBNX N/A
  • NXP $14.02
  • Average True Range (ATR)
  • BBNX 0.00
  • NXP 0.08
  • MACD
  • BBNX 0.00
  • NXP -0.00
  • Stochastic Oscillator
  • BBNX 0.00
  • NXP 27.59

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a diversified closed-end investment company. It seeks to provide current income and stable dividends, exempt from regular federal and designated state income taxes, consistent with the preservation of capital by investing primarily in a portfolio of municipal obligations.

Share on Social Networks: